A latest study outcome indicates that sTMS could provide relief from migraine headache among those suffering from migraine with aura.
A convenient contrivance which employs magnetic pulses for zapping pain holds immense potential as a new-fangled treatment for those ailing from a prevalent form of migraine.
In comparison to the patients that were given placebo treatments, a larger number of patients that underwent treatment with the investigational gadget, called as sTMS or single-pulse transcranial magnetic stimulation found relief from migraine headache soon after 2 hours of use.
The American Headache Society has estimated that nearly thirty-five million people from the United States have migraines and nearly twenty to thirty percent of them experienced headaches which normally occurred following ocular or other sensory caveat indicators.
Medical terminology for this condition is known as migraine with aura, aura-linked caveat signs could comprise of witnessing blinking lights or crisscross patterns, sightlessness or blind spots in a single or both the eyes, a prickly sensation felt on the skin’s surface and at times ocular and hearing delusions.
Medications prevalently employed for providing relief from migraine headache are usually not deemed effectual in attacks arising due to migraine with aura. There are several sufferers who do not wish to use drugs for treating their migraines. A number of individuals are not able to tolerate the medication treatments that properly and other people who would prefer steering clear of medications.
Headache specialist cum neurologist, director, Montefiore Headache Center, Bronx along with his associates evaluated the efficacy and safety quotient of a handy sTMS gadget in a trial that enrolled 201 entrants all of whom suffered from migraine-with-aura, treatment conducted at sixteen medical centers spread all over the country.
The sTMS gadget was given to nearly half the entrants for home-usage. The remnant people were given a similar appearing gadget which did not emanate any magnetic pulses.
The thought behind sTMS gadget is that the electrical events in the brain that elicit migraines could be disrupted magnetically.
Before participating in the trial, the patients experienced from 1to 8 migraine-with-auras during a month’s time.
These patients were advised applying the contrivances to the backside of their heads when they sensed an approaching headache and administering 2 pulses in such scenario.
The patients were additionally requested to note down the levels of pain they experienced instantaneously subsequent to the treatment and then once more at time intervals of thirty minutes, twenty-four hours and forty-eight hours afterwards.
From the 164 entrants that did recording of their migraine attacks in the course of the trial, thirty-nine percent in the sTMS set cited respite from the pain 2 hours following treatment in comparison to the twenty-two percent in the placebo set.
There was no significant variation in intensity of migraine-linked noise and light sensitiveness and feeling nauseous was noted in the two sets.
The trial has been backed by the Neurolieve of Sunnyvale, California which is hopeful of marketing the handy sTMS gadget as a cure for migraine with aura, in anticipation of FDA nod.
A number of queries have been raised by migraine investigator and neurologist, Hans-Christoph Diener from Univ. Hospital Essen, Germany about the handy sTMS being an effectual treatment for those suffering from migraine with aura and if repeated TMS has greater efficacy as compared to 1-pulse TMS. He further added that it was especially significant as the study was unable to illustrate efficiency in a second crucial final result in migraine trials, specifically the enhancement from moderate-ranging headaches to mild-ranging or zilch headaches.